カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の組換えヒト化コラーゲン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Recombinant Humanized Collagen Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19599）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19599
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の組換えヒト化コラーゲン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

組換えヒト化コラーゲン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の組換えヒト化コラーゲンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

組換えヒト化コラーゲン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・Ⅰ型コラーゲン、Ⅲ型コラーゲン、その他

用途別セグメントは次のように区分されます。
・食品ヘルスケア、美容化粧品、バイオ医療素材

世界の組換えヒト化コラーゲン市場の主要な市場プレーヤーは以下のとおりです。
・ACROBiosystems、FineTest、Evonik、Giant Biogene、Shanxi Jinbo Bio-Pharmaceutical、Jiangsu JLand Biotech、Jiangsu Chuangjian Medical Technology、JY-RAN

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、組換えヒト化コラーゲン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な組換えヒト化コラーゲンメーカーの企業概要、2019年～2022年までの組換えヒト化コラーゲンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な組換えヒト化コラーゲンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別組換えヒト化コラーゲンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの組換えヒト化コラーゲンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での組換えヒト化コラーゲン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および組換えヒト化コラーゲンの産業チェーンを掲載しています。
・第13、14、15章では、組換えヒト化コラーゲンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 組換えヒト化コラーゲンの概要
- 種類別分析（2017年vs2021年vs2028年）：Ⅰ型コラーゲン、Ⅲ型コラーゲン、その他
- 用途別分析（2017年vs2021年vs2028年）：食品ヘルスケア、美容化粧品、バイオ医療素材
- 世界の組換えヒト化コラーゲン市場規模・予測
- 世界の組換えヒト化コラーゲン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ACROBiosystems、FineTest、Evonik、Giant Biogene、Shanxi Jinbo Bio-Pharmaceutical、Jiangsu JLand Biotech、Jiangsu Chuangjian Medical Technology、JY-RAN
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：Ⅰ型コラーゲン、Ⅲ型コラーゲン、その他
・用途別分析2017年-2028年：食品ヘルスケア、美容化粧品、バイオ医療素材
・組換えヒト化コラーゲンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・組換えヒト化コラーゲンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・組換えヒト化コラーゲンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・組換えヒト化コラーゲンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・組換えヒト化コラーゲンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Recombinant Humanized Collagen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant Humanized Collagen market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Food Health Care accounting for % of the Recombinant Humanized Collagen global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Type I Collagen segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Recombinant Humanized Collagen include ACROBiosystems, FineTest, Evonik, Giant Biogene, and Shanxi Jinbo Bio-Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant Humanized Collagen market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Type I Collagen
Type Ⅲ Collagen
Others
Market segment by Application can be divided into
Food Health Care
Beauty Cosmetics
Biomedical Materials
The key market players for global Recombinant Humanized Collagen market are listed below:
ACROBiosystems
FineTest
Evonik
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
JY-RAN
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Humanized Collagen product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Humanized Collagen, with price, sales, revenue and global market share of Recombinant Humanized Collagen from 2019 to 2022.
Chapter 3, the Recombinant Humanized Collagen competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Humanized Collagen breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Humanized Collagen market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Humanized Collagen.
Chapter 13, 14, and 15, to describe Recombinant Humanized Collagen sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Recombinant Humanized Collagen Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Humanized Collagen Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Type I Collagen
1.2.3 Type Ⅲ Collagen
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Humanized Collagen Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Food Health Care
1.3.3 Beauty Cosmetics
1.3.4 Biomedical Materials
1.4 Global Recombinant Humanized Collagen Market Size & Forecast
1.4.1 Global Recombinant Humanized Collagen Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Recombinant Humanized Collagen Sales in Volume (2017-2028)
1.4.3 Global Recombinant Humanized Collagen Price (2017-2028)
1.5 Global Recombinant Humanized Collagen Production Capacity Analysis
1.5.1 Global Recombinant Humanized Collagen Total Production Capacity (2017-2028)
1.5.2 Global Recombinant Humanized Collagen Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Humanized Collagen Market Drivers
1.6.2 Recombinant Humanized Collagen Market Restraints
1.6.3 Recombinant Humanized Collagen Trends Analysis
2 Manufacturers Profiles
2.1 ACROBiosystems
2.1.1 ACROBiosystems Details
2.1.2 ACROBiosystems Major Business
2.1.3 ACROBiosystems Recombinant Humanized Collagen Product and Services
2.1.4 ACROBiosystems Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 FineTest
2.2.1 FineTest Details
2.2.2 FineTest Major Business
2.2.3 FineTest Recombinant Humanized Collagen Product and Services
2.2.4 FineTest Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Evonik
2.3.1 Evonik Details
2.3.2 Evonik Major Business
2.3.3 Evonik Recombinant Humanized Collagen Product and Services
2.3.4 Evonik Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Giant Biogene
2.4.1 Giant Biogene Details
2.4.2 Giant Biogene Major Business
2.4.3 Giant Biogene Recombinant Humanized Collagen Product and Services
2.4.4 Giant Biogene Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shanxi Jinbo Bio-Pharmaceutical
2.5.1 Shanxi Jinbo Bio-Pharmaceutical Details
2.5.2 Shanxi Jinbo Bio-Pharmaceutical Major Business
2.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product and Services
2.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jiangsu JLand Biotech
2.6.1 Jiangsu JLand Biotech Details
2.6.2 Jiangsu JLand Biotech Major Business
2.6.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Product and Services
2.6.4 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Jiangsu Chuangjian Medical Technology
2.7.1 Jiangsu Chuangjian Medical Technology Details
2.7.2 Jiangsu Chuangjian Medical Technology Major Business
2.7.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product and Services
2.7.4 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 JY-RAN
2.8.1 JY-RAN Details
2.8.2 JY-RAN Major Business
2.8.3 JY-RAN Recombinant Humanized Collagen Product and Services
2.8.4 JY-RAN Recombinant Humanized Collagen Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Recombinant Humanized Collagen Breakdown Data by Manufacturer
3.1 Global Recombinant Humanized Collagen Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Recombinant Humanized Collagen Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Recombinant Humanized Collagen
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Humanized Collagen Manufacturer Market Share in 2021
3.4.2 Top 6 Recombinant Humanized Collagen Manufacturer Market Share in 2021
3.5 Global Recombinant Humanized Collagen Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Recombinant Humanized Collagen Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Humanized Collagen Market Size by Region
4.1.1 Global Recombinant Humanized Collagen Sales in Volume by Region (2017-2028)
4.1.2 Global Recombinant Humanized Collagen Revenue by Region (2017-2028)
4.2 North America Recombinant Humanized Collagen Revenue (2017-2028)
4.3 Europe Recombinant Humanized Collagen Revenue (2017-2028)
4.4 Asia-Pacific Recombinant Humanized Collagen Revenue (2017-2028)
4.5 South America Recombinant Humanized Collagen Revenue (2017-2028)
4.6 Middle East and Africa Recombinant Humanized Collagen Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Recombinant Humanized Collagen Sales in Volume by Type (2017-2028)
5.2 Global Recombinant Humanized Collagen Revenue by Type (2017-2028)
5.3 Global Recombinant Humanized Collagen Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Recombinant Humanized Collagen Sales in Volume by Application (2017-2028)
6.2 Global Recombinant Humanized Collagen Revenue by Application (2017-2028)
6.3 Global Recombinant Humanized Collagen Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Humanized Collagen Sales by Type (2017-2028)
7.2 North America Recombinant Humanized Collagen Sales by Application (2017-2028)
7.3 North America Recombinant Humanized Collagen Market Size by Country
7.3.1 North America Recombinant Humanized Collagen Sales in Volume by Country (2017-2028)
7.3.2 North America Recombinant Humanized Collagen Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Humanized Collagen Sales by Type (2017-2028)
8.2 Europe Recombinant Humanized Collagen Sales by Application (2017-2028)
8.3 Europe Recombinant Humanized Collagen Market Size by Country
8.3.1 Europe Recombinant Humanized Collagen Sales in Volume by Country (2017-2028)
8.3.2 Europe Recombinant Humanized Collagen Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Recombinant Humanized Collagen Sales by Type (2017-2028)
9.2 Asia-Pacific Recombinant Humanized Collagen Sales by Application (2017-2028)
9.3 Asia-Pacific Recombinant Humanized Collagen Market Size by Region
9.3.1 Asia-Pacific Recombinant Humanized Collagen Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Recombinant Humanized Collagen Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Recombinant Humanized Collagen Sales by Type (2017-2028)
10.2 South America Recombinant Humanized Collagen Sales by Application (2017-2028)
10.3 South America Recombinant Humanized Collagen Market Size by Country
10.3.1 South America Recombinant Humanized Collagen Sales in Volume by Country (2017-2028)
10.3.2 South America Recombinant Humanized Collagen Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Humanized Collagen Sales by Type (2017-2028)
11.2 Middle East & Africa Recombinant Humanized Collagen Sales by Application (2017-2028)
11.3 Middle East & Africa Recombinant Humanized Collagen Market Size by Country
11.3.1 Middle East & Africa Recombinant Humanized Collagen Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Recombinant Humanized Collagen Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Recombinant Humanized Collagen and Key Manufacturers
12.2 Manufacturing Costs Percentage of Recombinant Humanized Collagen
12.3 Recombinant Humanized Collagen Production Process
12.4 Recombinant Humanized Collagen Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Recombinant Humanized Collagen Typical Distributors
13.3 Recombinant Humanized Collagen Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Recombinant Humanized Collagen Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Recombinant Humanized Collagen Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 4. ACROBiosystems Major Business
Table 5. ACROBiosystems Recombinant Humanized Collagen Product and Services
Table 6. ACROBiosystems Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. FineTest Basic Information, Manufacturing Base and Competitors
Table 8. FineTest Major Business
Table 9. FineTest Recombinant Humanized Collagen Product and Services
Table 10. FineTest Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Evonik Basic Information, Manufacturing Base and Competitors
Table 12. Evonik Major Business
Table 13. Evonik Recombinant Humanized Collagen Product and Services
Table 14. Evonik Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Giant Biogene Basic Information, Manufacturing Base and Competitors
Table 16. Giant Biogene Major Business
Table 17. Giant Biogene Recombinant Humanized Collagen Product and Services
Table 18. Giant Biogene Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Shanxi Jinbo Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Shanxi Jinbo Bio-Pharmaceutical Major Business
Table 21. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product and Services
Table 22. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Jiangsu JLand Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu JLand Biotech Major Business
Table 25. Jiangsu JLand Biotech Recombinant Humanized Collagen Product and Services
Table 26. Jiangsu JLand Biotech Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Jiangsu Chuangjian Medical Technology Basic Information, Manufacturing Base and Competitors
Table 28. Jiangsu Chuangjian Medical Technology Major Business
Table 29. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product and Services
Table 30. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. JY-RAN Basic Information, Manufacturing Base and Competitors
Table 32. JY-RAN Major Business
Table 33. JY-RAN Recombinant Humanized Collagen Product and Services
Table 34. JY-RAN Recombinant Humanized Collagen Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Recombinant Humanized Collagen Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 36. Global Recombinant Humanized Collagen Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Recombinant Humanized Collagen, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Recombinant Humanized Collagen Production Capacity by Company, (MT): 2020 VS 2021
Table 39. Head Office and Recombinant Humanized Collagen Production Site of Key Manufacturer
Table 40. Recombinant Humanized Collagen New Entrant and Capacity Expansion Plans
Table 41. Recombinant Humanized Collagen Mergers & Acquisitions in the Past Five Years
Table 42. Global Recombinant Humanized Collagen Sales by Region (2017-2022) & (MT)
Table 43. Global Recombinant Humanized Collagen Sales by Region (2023-2028) & (MT)
Table 44. Global Recombinant Humanized Collagen Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Recombinant Humanized Collagen Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Recombinant Humanized Collagen Sales by Type (2017-2022) & (MT)
Table 47. Global Recombinant Humanized Collagen Sales by Type (2023-2028) & (MT)
Table 48. Global Recombinant Humanized Collagen Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Recombinant Humanized Collagen Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Recombinant Humanized Collagen Price by Type (2017-2022) & (USD/Kg)
Table 51. Global Recombinant Humanized Collagen Price by Type (2023-2028) & (USD/Kg)
Table 52. Global Recombinant Humanized Collagen Sales by Application (2017-2022) & (MT)
Table 53. Global Recombinant Humanized Collagen Sales by Application (2023-2028) & (MT)
Table 54. Global Recombinant Humanized Collagen Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Recombinant Humanized Collagen Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Recombinant Humanized Collagen Price by Application (2017-2022) & (USD/Kg)
Table 57. Global Recombinant Humanized Collagen Price by Application (2023-2028) & (USD/Kg)
Table 58. North America Recombinant Humanized Collagen Sales by Country (2017-2022) & (MT)
Table 59. North America Recombinant Humanized Collagen Sales by Country (2023-2028) & (MT)
Table 60. North America Recombinant Humanized Collagen Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Recombinant Humanized Collagen Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Recombinant Humanized Collagen Sales by Type (2017-2022) & (MT)
Table 63. North America Recombinant Humanized Collagen Sales by Type (2023-2028) & (MT)
Table 64. North America Recombinant Humanized Collagen Sales by Application (2017-2022) & (MT)
Table 65. North America Recombinant Humanized Collagen Sales by Application (2023-2028) & (MT)
Table 66. Europe Recombinant Humanized Collagen Sales by Country (2017-2022) & (MT)
Table 67. Europe Recombinant Humanized Collagen Sales by Country (2023-2028) & (MT)
Table 68. Europe Recombinant Humanized Collagen Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Recombinant Humanized Collagen Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Recombinant Humanized Collagen Sales by Type (2017-2022) & (MT)
Table 71. Europe Recombinant Humanized Collagen Sales by Type (2023-2028) & (MT)
Table 72. Europe Recombinant Humanized Collagen Sales by Application (2017-2022) & (MT)
Table 73. Europe Recombinant Humanized Collagen Sales by Application (2023-2028) & (MT)
Table 74. Asia-Pacific Recombinant Humanized Collagen Sales by Region (2017-2022) & (MT)
Table 75. Asia-Pacific Recombinant Humanized Collagen Sales by Region (2023-2028) & (MT)
Table 76. Asia-Pacific Recombinant Humanized Collagen Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Recombinant Humanized Collagen Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Recombinant Humanized Collagen Sales by Type (2017-2022) & (MT)
Table 79. Asia-Pacific Recombinant Humanized Collagen Sales by Type (2023-2028) & (MT)
Table 80. Asia-Pacific Recombinant Humanized Collagen Sales by Application (2017-2022) & (MT)
Table 81. Asia-Pacific Recombinant Humanized Collagen Sales by Application (2023-2028) & (MT)
Table 82. South America Recombinant Humanized Collagen Sales by Country (2017-2022) & (MT)
Table 83. South America Recombinant Humanized Collagen Sales by Country (2023-2028) & (MT)
Table 84. South America Recombinant Humanized Collagen Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Recombinant Humanized Collagen Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Recombinant Humanized Collagen Sales by Type (2017-2022) & (MT)
Table 87. South America Recombinant Humanized Collagen Sales by Type (2023-2028) & (MT)
Table 88. South America Recombinant Humanized Collagen Sales by Application (2017-2022) & (MT)
Table 89. South America Recombinant Humanized Collagen Sales by Application (2023-2028) & (MT)
Table 90. Middle East & Africa Recombinant Humanized Collagen Sales by Region (2017-2022) & (MT)
Table 91. Middle East & Africa Recombinant Humanized Collagen Sales by Region (2023-2028) & (MT)
Table 92. Middle East & Africa Recombinant Humanized Collagen Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Recombinant Humanized Collagen Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Recombinant Humanized Collagen Sales by Type (2017-2022) & (MT)
Table 95. Middle East & Africa Recombinant Humanized Collagen Sales by Type (2023-2028) & (MT)
Table 96. Middle East & Africa Recombinant Humanized Collagen Sales by Application (2017-2022) & (MT)
Table 97. Middle East & Africa Recombinant Humanized Collagen Sales by Application (2023-2028) & (MT)
Table 98. Recombinant Humanized Collagen Raw Material
Table 99. Key Manufacturers of Recombinant Humanized Collagen Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Recombinant Humanized Collagen Typical Distributors
Table 103. Recombinant Humanized Collagen Typical Customers
List of Figures
Figure 1. Recombinant Humanized Collagen Picture
Figure 2. Global Recombinant Humanized Collagen Revenue Market Share by Type in 2021
Figure 3. Type I Collagen
Figure 4. Type Ⅲ Collagen
Figure 5. Others
Figure 6. Global Recombinant Humanized Collagen Revenue Market Share by Application in 2021
Figure 7. Food Health Care
Figure 8. Beauty Cosmetics
Figure 9. Biomedical Materials
Figure 10. Global Recombinant Humanized Collagen Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 11. Global Recombinant Humanized Collagen Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Recombinant Humanized Collagen Sales (2017-2028) & (MT)
Figure 13. Global Recombinant Humanized Collagen Price (2017-2028) & (USD/Kg)
Figure 14. Global Recombinant Humanized Collagen Production Capacity (2017-2028) & (MT)
Figure 15. Global Recombinant Humanized Collagen Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Recombinant Humanized Collagen Market Drivers
Figure 17. Recombinant Humanized Collagen Market Restraints
Figure 18. Recombinant Humanized Collagen Market Trends
Figure 19. Global Recombinant Humanized Collagen Sales Market Share by Manufacturer in 2021
Figure 20. Global Recombinant Humanized Collagen Revenue Market Share by Manufacturer in 2021
Figure 21. Recombinant Humanized Collagen Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Recombinant Humanized Collagen Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Recombinant Humanized Collagen Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Recombinant Humanized Collagen Sales Market Share by Region (2017-2028)
Figure 25. Global Recombinant Humanized Collagen Revenue Market Share by Region (2017-2028)
Figure 26. North America Recombinant Humanized Collagen Revenue (2017-2028) & (USD Million)
Figure 27. Europe Recombinant Humanized Collagen Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Recombinant Humanized Collagen Revenue (2017-2028) & (USD Million)
Figure 29. South America Recombinant Humanized Collagen Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Recombinant Humanized Collagen Revenue (2017-2028) & (USD Million)
Figure 31. Global Recombinant Humanized Collagen Sales Market Share by Type (2017-2028)
Figure 32. Global Recombinant Humanized Collagen Revenue Market Share by Type (2017-2028)
Figure 33. Global Recombinant Humanized Collagen Price by Type (2017-2028) & (USD/Kg)
Figure 34. Global Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
Figure 35. Global Recombinant Humanized Collagen Revenue Market Share by Application (2017-2028)
Figure 36. Global Recombinant Humanized Collagen Price by Application (2017-2028) & (USD/Kg)
Figure 37. North America Recombinant Humanized Collagen Sales Market Share by Type (2017-2028)
Figure 38. North America Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
Figure 39. North America Recombinant Humanized Collagen Sales Market Share by Country (2017-2028)
Figure 40. North America Recombinant Humanized Collagen Revenue Market Share by Country (2017-2028)
Figure 41. United States Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Recombinant Humanized Collagen Sales Market Share by Type (2017-2028)
Figure 45. Europe Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
Figure 46. Europe Recombinant Humanized Collagen Sales Market Share by Country (2017-2028)
Figure 47. Europe Recombinant Humanized Collagen Revenue Market Share by Country (2017-2028)
Figure 48. Germany Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Recombinant Humanized Collagen Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Recombinant Humanized Collagen Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Recombinant Humanized Collagen Revenue Market Share by Region (2017-2028)
Figure 57. China Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Recombinant Humanized Collagen Sales Market Share by Type (2017-2028)
Figure 64. South America Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
Figure 65. South America Recombinant Humanized Collagen Sales Market Share by Country (2017-2028)
Figure 66. South America Recombinant Humanized Collagen Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Recombinant Humanized Collagen Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Recombinant Humanized Collagen Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Recombinant Humanized Collagen in 2021
Figure 78. Manufacturing Process Analysis of Recombinant Humanized Collagen
Figure 79. Recombinant Humanized Collagen Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の組換えコラーゲン市場2022年：市場規模予測（～2028年）
  • 遺伝子組み換えコラーゲン医療美容注射のグローバル市場展望 2023年-2029年：植物由来コラーゲン、動物由来コラーゲン
  • 組換えIII型コラーゲンのグローバル市場展望 2023年-2029年：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他
  • 世界のアンチトロンビン（組換え）市場2022年：市場規模予測（～2028年）
  • 世界のフォン・ヴィレブランド因子（組換え）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19599 )"世界の組換えヒト化コラーゲン市場2022年：市場規模予測（～2028年）" (英文：Global Recombinant Humanized Collagen Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。